Protherics turns a profit

Inflammation and infectious disease company Protherics (LSE:PTI) reported its first profitable year. For the year ended March 31, PTI reported EPS of 0.61p compared to a loss of 0.13p in 2003. Revenues came in at L21 million ($37.5 million), up 86% from L11.3 million ($20.2 million) in the same period last year. ...